🕒 Wednesday 22 October 2025 Wed, 22 Oct 2025

Aeris Resources reported solid Q1 FY26 results with steady copper and gold production, disciplined cost management, and advancing divestment plans for non-core assets.

Aeris Resources reported steady Q1 FY26 production with 10.3kt copper equivalent at AISC of A$4.64/lb, alongside significant growth capital investment and promising exploration results.

Dateline Resources’ Managing Director Stephen Baghdadi has increased his personal investment by exercising 13.86 million options, reinforcing confidence in the Colosseum Gold and Rare Earth Elements Project as feasibility studies progress.

MedAdvisor Solutions reported a steep 52.8% revenue decline in Q1 FY26, impacted by US regulatory pressures and vaccine program delays, while embarking on a strategic transformation to restore growth.

Jupiter Energy reported steady oil sales of US$1.65 million in Q3 2025, all through domestic channels, while nearing completion of a key gas pipeline integration that promises operational efficiencies.

MedAdvisor reports a sharp 53% drop in 1Q FY26 revenue driven by U.S. regulatory and sector challenges, while advancing a major platform transformation and selling its ANZ business to emerge debt-free.

Greatland Resources has kicked off FY26 with a drilling program at Telfer that has already surpassed targets, revealing a promising new high-grade zone underground and advancing multiple resource extensions.

Arrow Minerals Limited has suspended all field activities in Guinea due to unresolved questions over exploration permit renewals, maintaining a cautious financial stance while awaiting government clarity.

Resolution Minerals is fast-tracking its downstream antimony strategy in Idaho, aiming to become a key US supplier while preparing for a Nasdaq listing with Tribeca Capital's support.

Vitasora Health has received $2.43 million from a cornerstone investor, advancing its $11 million capital raise and reinforcing its path to profitability by Q4 FY2026. The company’s expanding US partnerships and technology investments signal growing market confidence.

Element 25 has appointed Altris Engineering to lead the AU$64.8 million expansion of its Butcherbird manganese mine, a move that underpins its strategy to supply high-purity battery materials to the US electric vehicle market.

Diablo Resources is broadening its North American footprint by preparing for a secondary listing on the U.S. OTCQB market, complementing its recent acquisition of a high-grade silver-antimony project in Utah.

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.

Gorilla Gold Mines Ltd has raised A$31.7 million through a placement to accelerate exploration and resource growth at its key Western Australian gold projects. The capital injection strengthens the company’s cash position to about A$42 million, supporting ongoing and planned drilling campaigns.

Apiam Animal Health Limited has entered a binding agreement with Adamantem Capital Fund II for a $228.4 million acquisition via a scheme of arrangement, offering shareholders a significant premium and flexible cash or scrip consideration options.

ACDC Metals reports compelling mineralogy results from its Goschen Central project, highlighting elevated rare earth element grades that reinforce its economic potential. The announcement coincides with strategic momentum from the Australia-US Critical Minerals Framework, positioning the project as a key player in global supply chains.

Eden Innovations reports a surge in US orders and quotations for its OptiBlend dual fuel kits, driven by growing demand from data centres. Recent sales exceed US$300k, with a robust pipeline of US$4.4 million signalling strong market momentum.

National Storage REIT delivered robust FY25 results, surpassing earnings guidance and expanding its development pipeline, while advancing sustainability and technology initiatives.

Volt Resources has reached a key technical milestone by consistently producing ultra-high purity graphite using a proprietary, hydrofluoric acid-free process, paving the way for U.S.-based battery-grade graphite production.

Hancock & Gore’s transformation into Schoolblazer Limited marks a strategic pivot following the Trutex UK acquisition, setting sights on $200 million revenue and expanded global reach by FY27.

Zuleika Gold has locked in $5 million in funding to boost exploration efforts and strengthen its financial footing in Western Australia's prolific gold belt.

Island Pharmaceuticals secures FDA confirmation that regulatory feedback on Galidesivir’s approval pathway will arrive on schedule, underscoring the drug’s strategic importance amid US government disruptions.

Accelerate Resources has reported impressive high-grade gold assay results from its newly acquired Balagundi Gold Project near Kalgoorlie, with grades reaching up to 32.9 g/t Au. The company is gearing up for maiden drilling in November 2025 to further explore these promising targets.

Peel Mining has significantly increased its Share Purchase Plan to $5 million following overwhelming shareholder interest, reflecting strong confidence in its Cobar Basin assets.